Rush Immunotherapy: Experience with a One-Day Schedule

作者: Paul Sharkey , Jay Portnoy

DOI: 10.1016/S1081-1206(10)63419-9

关键词: Maintenance doseImmunotherapyAnesthesiaSurgeryDesensitization (medicine)AsthmaPrednisoneMedicineAnaphylaxisPremedicationOutpatient clinic

摘要: Introduction Rush immunotherapy is a method for rapidly desensitizing patients to inhalant allergens. The frequency of systemic reactions during rush similar conventional when premedication used. most rapid protocol reported date requires one and one-half days which inconvenient clinic schedules. To improve this situation decrease the cost giving immunotherapy, we have developed 1-day protocol. Methods For ongoing study, 22 allergic received consisting 8 injections over 6 hours followed by 2 observation in an outpatient clinic. Five had rhinitis rest asthma, 7 whom were steroid-dependent. All premedicated with astemizole, ranitidine, prednisone 3 including day peak expiratory flow rates monitored. Results Systemic seen 5 (23%). They occurred following sixth injection (1), seventh (2), or final (2) consisted primarily pulmonary symptoms episode mild anaphylaxis. A reaction was only 1 steroid-dependent asthmatic patient. local preceded but reached maintenance dose day. responded epinephrine all could go home after immunotherapy. Only patient months Conclusions One-day tolerated rate comparable able reach sooner than weekly With refinement procedure, may become widely used allergens, make immunotherapyless expensive more convenient.

参考文章(17)
Portnoy J, Barnes C, Pacheco F, Bagstad K, Kanarek H, Hall B, Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts. Annals of allergy. ,vol. 73, pp. 409- 418 ,(1994)
Janosky J, Henry J, Friday Ga, Mandik L, Lower T, Compliance with allergen immunotherapy. Annals of allergy. ,vol. 70, pp. 480- 482 ,(1993)
J BOUSQUET, P CALVAYRAC, B GUERIN, A HEJJAOUI, H DHIVERT, B HEWITT, F MICHEL, Immunotherapy with a standardized Dermatophagoides pteronyssinus extract: I. In vivo and in vitro parameters after a short course of treatment☆ The Journal of Allergy and Clinical Immunology. ,vol. 76, pp. 734- 744 ,(1985) , 10.1016/0091-6749(85)90680-3
Makoto NAGATA, Hideaki YAMAMOTO, Kazuaki TABE, Isao KIMURA, Isao HOUYA, Kaoru KURAMITSU, Hidenori KIUCHI, Yukiyoshi YANAGIHARA, Yoshio SAKAMOTO, Keiichiro YAMAMOTO, Yutaka DOHI, Effect of rush immunotherapy in house-dust-mite (HDM)-sensitive adult bronchial asthma : changes in in vivo and in vitro responses to HDM Internal Medicine. ,vol. 32, pp. 702- 709 ,(1993) , 10.2169/INTERNALMEDICINE.32.702
J COHN, A PIZZI, Determinants of patient compliance with allergen immunotherapy The Journal of Allergy and Clinical Immunology. ,vol. 91, pp. 734- 737 ,(1993) , 10.1016/0091-6749(93)90192-I
A HEJJAOUI, R FERRANDO, H DHIVERT, F MICHEL, J BOUSQUET, Systemic reactions occurring during immunotherapy with standardized pollen extracts. The Journal of Allergy and Clinical Immunology. ,vol. 89, pp. 925- 933 ,(1992) , 10.1016/0091-6749(92)90214-M
D BERNSTEIN, R MITTMAN, S KAGEN, L KORBEE, M ENRIONE, I BERNSTEIN, Clinical and immunologic studies of rapid venom immunotherapy in Hymenoptera-sensitive patients The Journal of Allergy and Clinical Immunology. ,vol. 84, pp. 951- 959 ,(1989) , 10.1016/0091-6749(89)90394-1
G.Edward Stewart, Richard F. Lockey, Systemic reactions from allergen immunotherapy The Journal of Allergy and Clinical Immunology. ,vol. 90, pp. 567- 578 ,(1992) , 10.1016/0091-6749(92)90129-P